Video abstract Similar content being viewed by others 1 Introduction The principal goal of disease management in type 2 diabetes (T2D) is the prevention or delay of both microvascular and macrovascular complications through the achievement of good glycemic control and, where necessary, weight loss and cardiovascular (CV) risk factor management [1]
Una storia centenaria, un business consolidato nel trattamento del diabete, una crescita esponenziale dovuta ai nuovi farmaci GLP-1 per la gestione dell'obesit
You should have these injections administered by a licensed and experienced medical professional to lessen or lessen the severity of side effects
(2) nuclear translocation of NF-B
J Biol Chem 267: 7402-7405, 1992
On the other hand, in people with type 2 diabetes, exendin 9-39 increased fasting (12 2 pmol/min versus 17 2 pmol/min, P = 0.01) and nadir (6 1 pmol/min versus 9 2 pmol/min, P = 0.02) glucagon secretion